title: Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here?
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Urban
authors.forename: David B
authors.initials: DB
authors.lastname: Goldstein
authors.forename: Paul B
authors.initials: PB
authors.lastname: Watkins
mesh_terms: D001191:Arylamine N-Acetyltransferase / Q000235:genetics; D056486:Chemical and Drug Induced Liver Injury / Q000235:genetics*; D005436:Floxacillin / Q000009:adverse effects / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use; D020641:Polymorphism, Single Nucleotide; D050797:STAT4 Transcription Factor
chemical_list: D050797:STAT4 Transcription Factor; C494090:STAT4 protein, human; D005436:Floxacillin; D001191:Arylamine N-Acetyltransferase; C478900:NAT2 protein, human; D007538:Isoniazid